Cargando…
Mutation of the PIK3CA oncogene in human cancers
It is now well established that cancer is a genetic disease and that somatic mutations of oncogenes and tumour suppressor genes are the initiators of the carcinogenic process. The phosphatidylinositol 3-kinase signalling pathway has previously been implicated in tumorigenesis, and evidence over the...
Autores principales: | Karakas, B, Bachman, K E, Park, B H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361173/ https://www.ncbi.nlm.nih.gov/pubmed/16449998 http://dx.doi.org/10.1038/sj.bjc.6602970 |
Ejemplares similares
-
Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma
por: Qiu, Wanglong, et al.
Publicado: (2014) -
Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
por: Murat, C.B., et al.
Publicado: (2012) -
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Hao, Yujun, et al.
Publicado: (2016) -
Activation of diverse signaling pathways by oncogenic PIK3CA mutations
por: Wu, Xinyan, et al.
Publicado: (2014) -
PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)